CLINICAL TRIALS PROFILE FOR HETRAZAN
✉ Email this page to a colleague
All Clinical Trials for HETRAZAN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04410406 ↗ | Moxidectin for LF, Cote d'Ivoire (DOLF) | Enrolling by invitation | Case Western Reserve University | Phase 3 | 2020-08-20 | The purpose of this study is to determine whether moxidectin (Mox) will be more effective than ivermectin (IVM) when used in single-dose combination therapies for lymphatic filariasis (LF). |
NCT04410406 ↗ | Moxidectin for LF, Cote d'Ivoire (DOLF) | Enrolling by invitation | Regional Hospital of Agboville, Southern Cote d'Ivoire | Phase 3 | 2020-08-20 | The purpose of this study is to determine whether moxidectin (Mox) will be more effective than ivermectin (IVM) when used in single-dose combination therapies for lymphatic filariasis (LF). |
NCT04410406 ↗ | Moxidectin for LF, Cote d'Ivoire (DOLF) | Enrolling by invitation | Washington University School of Medicine | Phase 3 | 2020-08-20 | The purpose of this study is to determine whether moxidectin (Mox) will be more effective than ivermectin (IVM) when used in single-dose combination therapies for lymphatic filariasis (LF). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for HETRAZAN
Condition Name
Clinical Trial Progress for HETRAZAN
Clinical Trial Phase
Clinical Trial Sponsors for HETRAZAN
Sponsor Name